Technetium-99m labeled myocardial perfusion imaging agents
Open Access
- 1 July 1999
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 29 (3) , 221-236
- https://doi.org/10.1016/s0001-2998(99)80012-9
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomographyJournal of the American College of Cardiology, 1995
- Infarct Size After Acute Myocardial Infarction Measured by Quantitative Tomographic 99m Tc Sestamibi Imaging Predicts Subsequent MortalityCirculation, 1995
- Nuclear CardiologyNew England Journal of Medicine, 1993
- Nuclear CardiologyNew England Journal of Medicine, 1993
- Myocardial perfusion imaging with 99mTc-methoxy-isobutyl-isonitrile (MIBI): Comparison of short and long time intervals between rest and stress injectionsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1988
- Determination of the quantitative thallium imaging variables that optimize detection of coronary artery diseaseJournal of the American College of Cardiology, 1986
- Heart Imaging with Cationic Complexes of TechnetiumScience, 1981
- Value and Limitations of Thallium-201 Scintigraphy in the Acute Phase of Myocardial InfarctionNew England Journal of Medicine, 1976
- Potassium-43 Myocardial Perfusion Scanning for the Noninvasive Evaluation of Patients with False-Positive Exercise TestsCirculation, 1973
- Noninvasive Regional Myocardial Perfusion with Radioactive PotassiumNew England Journal of Medicine, 1973